What are the Challenges in Targeting the Warburg Effect?
One of the main challenges is that glycolysis is a fundamental process in all cells, not just cancer cells. Therefore, targeting enzymes in this pathway could also affect normal cells, leading to potential side effects. Another challenge is the heterogeneity of cancer cells; not all cancers exhibit the Warburg Effect to the same extent, making a one-size-fits-all approach difficult.
